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Alx1, a homeodomain-containing transcription factor, is a
highly conserved regulator of skeletogenesis in echinoderms. In
sea urchins, Alx1 plays a central role in the differentiation of
embryonic primary mesenchyme cells (PMCs) and positively
regulates the transcription of most biomineralization genes
expressed by these cells. The alx1 gene arose via duplication and
acquired a skeletogenic function distinct from its paralog (alx4)
through the exonization of a 41–amino acid motif (the D2
domain). Alx1 and Alx4 contain glutamine-50 paired-type
homeodomains, which interact preferentially with palindromic
binding sites in vitro. Chromatin immunoprecipitation
sequencing (ChIP-seq) studies have shown, however, that Alx1
binds both to palindromic and half sites in vivo. To address this
apparent discrepancy and explore the function of the D2
domain, we used an endogenous cis-regulatory module associated with Sp-mtmmpb, a gene that encodes a PMC-speciﬁc
metalloprotease, to analyze the DNA-binding properties of
Alx1. We ﬁnd that Alx1 forms dimeric complexes on TAATcontaining half sites by a mechanism distinct from the wellknown mechanism of dimerization on palindromic sites. We
used transgenic reporter assays to analyze the functional roles of
half sites in vivo and demonstrate that two sites with partially
redundant functions are essential for the PMC-speciﬁc activity of
the Sp-mtmmpb cis-regulatory module. Finally, we show that the
D2 domain inﬂuences the DNA-binding properties of Alx1
in vitro, suggesting that the exonization of this motif may have
facilitated the acquisition of new transcriptional targets and
consequently a novel developmental function.

Recent studies have highlighted the central, conserved role
of Alx1, a homeodomain (HD)-containing transcription factor
(TF), in the formation of the extensive, biomineralized endoskeleton characteristic of all echinoderms (1). In echinoderm
clades that form skeletons at early embryonic stages, Alx1 is
expressed speciﬁcally by skeletogenic cells and plays an
essential role in their speciﬁcation (2–4). In euechinoids,
where Alx1 function has been especially well studied, the

protein is a pivotal, early component of a well-characterized
gene regulatory network deployed in skeletogenic primary
mesenchyme cells (PMCs) (1). Alx1 provides direct, positive
inputs into a large fraction (more than one-third) of all genes
selectively expressed by PMCs and indirect, positive inputs
into many other genes in this class, highlighting the pivotal
role of Alx1 as a primary determinant of PMC identity (5–7).
Alx1 is also expressed selectively in the biomineralizing centers
of adult echinoderms, pointing to a role in what is widely
considered to be the ancestral mode of skeletogenesis within
the phylum (8–11). These observations establish alx1 as a
conserved, pivotal regulator of echinoderm skeletogenesis.
Strikingly, the closest relatives of echinoderm alx1 in vertebrates (Cart1/alx1, alx3, and alx4) also control the development of skeletal structures, including facial bones and the
scapula, in mice (12–16), humans (17–21), and other vertebrates (22, 23). Thus, alx1-related genes have a conserved role
in the control of biomineral formation across chordates (24).
The echinoderm alx1 gene arose early in the evolution of
the phylum via a gene duplication event, and Alx1 secondarily
acquired the skeletogenic function that it currently exhibits in
all echinoderms (11, 25). Acquisition of this new regulatory
function was associated with the exonization of a 41–amino
acid motif (the D2 domain) located between the HD and C
terminus of Alx1 (25). The Alx1 paralog, Alx4, lacks this motif,
but, remarkably, experimental insertion of the D2 domain is
sufﬁcient to confer robust skeletogenic function on Alx4.
Thus, Alx1 provides a particularly striking example of an
evolutionary change in TF sequence that has led to a major
shift in developmental function (26). Although Khor and
Ettensohn (2017) established an important role for the D2
domain in vivo, the biochemical function of this motif is unknown. In addition, although previous work has shown that
alx1 and alx4 encode HD proteins with markedly different
functional properties, in euechinoids, these two genes are
transiently coexpressed by PMCs during gastrulation (5, 6, 11),
raising the possibility that their protein products might
interact physically and/or functionally.
Alx1 contains a paired-class HD of the glutamine-50 (Q50)
type (27). In vitro binding studies have shown that paired-class
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DNA-binding properties of Alx1
HD proteins bind preferentially to palindromic sites that
contain inverted TAAT sequences (28, 29). This interaction
involves the cooperative binding of two protein molecules and
the formation of a trimeric protein–DNA complex, requires
only the HDs of the two protein molecules, and can be mediated by homodimers or heterodimers of paired-class HDs.
These same studies also revealed a preference of Q50 pairedclass HDs for palindromic sites in which the inverted TAAT
half-sites are separated by three base pairs (P3 sites). In vitro
binding studies with full-length human Cart1/Alx1 conﬁrmed a
preference for palindromic TAAT/ATTA sequences with 3 to 4
intervening base pairs, and reporter assays showed that such
palindromic sites can mediate Cart1-based transcriptional
activation (30, 31). Despite the evidence pointing to the
importance of dimerization on palindromic sites, other in vitro
binding studies have shown that paired-class HD proteins,
including the vertebrate Cart1/Alx3/Alx4 proteins, are capable
of interacting with half sites (also called monomeric sites), albeit
with lower afﬁnity (32). A recent, high-throughput reporter
analysis of binding sites for CRX, a paired-class HD protein,
found that dimeric binding sites were generally associated with
stronger enhancer activity than monomeric sites and conﬁrmed
the importance of three base pair spacing in palindromic sites
in vivo (33). The factors that regulate the binding of paired-class
HD TFs to palindromic and half sites in vivo, and possible
differences in the contributions of palindromic and half sites to
enhancer activity, remain important open questions. These
questions are also highly relevant to the newly evolved, skeletogenic properties of Alx1, as chromatin immunoprecipitation
sequencing (ChIP-seq) analysis has shown that Alx1 binds to
both palindromic and half sites in vivo (7).
In this study, we have examined the DNA-binding properties of Alx1, with special attention to the possible role of
the D2 domain, and have compared these properties to the
DNA-binding activity of the paralogous Alx4 protein. Using
an endogenous cis-regulatory module (CRM) associated with
Sp-mtmmpb, a gene that encodes a PMC-speciﬁc metalloprotease, and EMSA analysis, we show that Alx1 binds
directly to several half sites. Moreover, Alx1 forms dimeric
complexes at these sites and does so by a mechanism distinct
from the well-known mechanism of dimerization that occurs
at palindromic sites. We provide evidence that dimerization
of Alx1 on half sites is mediated by DNA-independent,
protein–protein interactions. To explore the potential functional role of half sites in vivo, we used transgenic reporter
assays to carry out a mutational dissection of the Sp-mtmmpb
CRM. The single palindromic site in this CRM is entirely
dispensable for activity; instead, two half-sites (sites A and B)
mediate PMC-speciﬁc reporter expression, and these two
sites act independently and largely redundantly. Finally, we
compared the DNA-binding properties of Alx1, Alx4, and a
mutant form of Alx1 that lacks the D2 domain (Alx1ΔD2),
using a validated, palindromic Alx1-binding site. We show
that the D2 domain inﬂuences the DNA-binding behavior
in vitro and propose that this may have supported the neofunctionalization of Alx1 by facilitating the acquisition of
new transcriptional targets.
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Results
Alx1 binds directly to endogenous half sites and can dimerize
on those sites
One of the CRMs identiﬁed in our ChIP-seq analysis of Alx1binding sites in Strongylocentrotus purpuratus (Sp) embryos (7)
contained four putative binding sites—three half sites and one
palindromic site. This 210-bp ChIP-seq peak was located near
the 50 end of Sp-mtmmpb, a gene that encodes a PMC-speciﬁc
metalloprotease (Fig. 1A). The Sp-mtmmpb ChIP-seq peak
overlapped regions of chromatin previously shown to be
hyperaccessible in PMCs relative to other embryonic cell types,
based on ATAC-seq and DNase-seq studies (1). Most importantly, this CRM was found to drive reporter gene expression
speciﬁcally in PMCs in transgenic embryos (7).
We examined the binding of Alx1 to each of the four putative Alx1-binding sites in the Sp-mtmmpb CRM using an
EMSA. For each probe tested, binding speciﬁcity was assessed
by adding excess nonbiotinylated, competitor DNA that had
the same sequence as the labeled probe or that had mutations
introduced into the putative Alx1-binding site. The binding of
full-length Alx1 (Alx1-FL), the Alx1 HD alone (Alx1-HD), and
Alx1ΔD2 was assayed. As an additional control, we used an
endogenous, palindromic Alx1-binding site located within a
CRM associated with Sp-EMI/TM, a gene that encodes a novel,
PMC-speciﬁc transmembrane protein (Fig. 1B). This Alx1binding site was previously shown to be required for the activity of a transcriptional reporter in transgenic sea urchin
embryos (7). It should be noted that although this sequence is
not perfectly palindromic, the single nucleotide difference does
not prevent dimerization of Alx1 (Figs. 2–5), consistent with
previous studies, which showed that slight deviations from
palindromic sequences can be accommodated without substantially affecting cooperative binding and dimer formation,
provided spacing between the half sites is preserved (28, 29).
Alx1-HD bound to the Sp-EMI/TM palindromic site (Fig. 2,
A and B, lanes 1–3) and site D (Fig. 2B, lanes 7–9) in both
monomeric and dimeric protein–DNA complexes. This
observation was consistent with what has been reported for
other paired-class HDs, which can bind cooperatively to
palindromic sites (28, 29, 34). Based on these ﬁndings, we
concluded that site D, which has the sequence TGATTCGATCA, functions as a canonical palindromic site. Alx1-HD
also bound to sites A and B but only as a monomer (Fig. 2A,
lanes 4 and 7, respectively), and this protein fragment interacted very weakly, if at all, with site C (Fig. 2B, lane 4).
When Alx1-FL and Alx1-ΔD2 were analyzed by EMSA, the
predominant molecular complexes that formed on the SpEMI/TM palindromic site were dimeric protein–DNA complexes (Fig. 2A, lanes 10 and 19; Fig. 2B, lanes 10 and 19). This
was also true in the case of site D (Fig. 2B, lanes 16 and 25),
further supporting the conclusion that site D functions as a
palindromic site. Monomeric protein–DNA complexes were
detected on sites A, B, and C (Fig. 2A, lanes 13, 16, 22, and 25;
Fig. 2B, lanes 13 and 22). Signiﬁcantly, a slower migrating
complex also formed in association with each of these sites and
was especially prominent in the case of site B (Fig. 2A, lanes 16
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Figure 1. Sp-Alx1 ChIP-seq peaks in the Sp-mtmmpb CRM used to identify Alx1-binding sites. A, genome tracks showing the location of the 210-bp SpAlx1 ChIP-seq peak (1166) in the 50 untranslated region of Sp-mtmmpb, overlapping ATAC-seq and DNase-seq differential peaks (i.e., regions of chromatin
selectively accessible in skeletogenic PMCs, cells that speciﬁcally express Sp-mtmmpb). Four putative Alx1-binding sites are present within ChIP-seq peak
1166. B, previously identiﬁed Sp-Alx1 ChIP-seq peak within an intron of Sp-EMI/TM. This region drives PMC-speciﬁc reporter expression in transgenic
embryos, and expression depends on the ﬁrst palindromic site (7). The DNA sequence of the ﬁrst site was used in the EMSA assays. CRM, cis-regulatory
module; PMCs, primary mesenchyme cells.

and 25). This larger complex exhibited a mobility indistinguishable from that of the protein dimer bound to a palindromic site. We therefore attributed the formation of this
complex to protein–protein interactions that promoted Alx1
dimerization on half sites, although presumably only one Alx1
molecule was bound tightly to DNA at these sites via its HD.
We also noted that, although Alx1-HD did not exhibit
appreciable binding to site C, Alx1-FL (and Alx1-ΔD2) interacted with this site to form primarily a monomeric complex
(Fig. 2B, lanes 13 and 22). This suggests that binding of Alx1 to
site C is inﬂuenced by domains of the protein other than
the HD.
In initial studies, we found that deletion of the D2 domain
did not prevent the formation of monomeric and dimeric
complexes on the Sp-EMI/TM palindromic site and on the
four Alx1-binding sites in the Sp-mtmmpb CRM (Fig. 2A, lanes
10–27; Fig. 2B, lanes 10–27). In several cases, however, it

appeared that the amounts of the complexes and/or the ratio
of monomeric to dimeric complexes was affected by deletion
of the D2 domain. To examine this issue further, we used
quantitative EMSAs to compare the ability of Alx1-FL and
Alx1-ΔD2 to bind to a Cy5-labeled Sp-EMI/TM palindromic
site (Fig. 3). We measured the active fraction of protein in each
preparation (see Experimental procedures) and titrated each
protein over a wide concentration range. These studies showed
that the deletion of the D2 domain had a reproducible effect
on the binding behavior of Alx1 (Fig. 3, A–C) and signiﬁcantly
reduced the ratio of dimeric complex to monomeric complex
at all protein concentrations tested (Fig. 3D).
Alx1–Alx1 interactions in the absence of DNA
EMSAs indicated that Alx1 formed dimers on half site B
(and, to a lesser extent, on half sites A and C) by a mechanism
J. Biol. Chem. (2021) 297(1) 100901
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Figure 2. EMSA analysis of the binding of puriﬁed Alx1-HD, Alx1-FL, and Alx1-ΔD2 proteins to the Sp-EMI/TM palindromic site and putative half
sites. Binding speciﬁcity was conﬁrmed by adding WT or mutant competitor. A, biotin-labeled probes containing the palindromic site, site A, or site B. B,
biotin-labeled probes containing the palindromic site, site C, or site D. For the complete sequences of all probes used in this study, see Table S1. A sample of
each puriﬁed protein was separated on SDS-PAGE gels and visualized by Coomassie staining (Fig. S1). Alx1-FL, full-length Alx1; Alx1-HD, Alx1 HD alone;
Alx1ΔD2, a mutant form of Alx1 that lacks the D2 domain; D, dimer; F, free probe; M, monomer.

distinct from the HD-mediated dimerization that occurs on
palindromic sites. It seemed plausible that dimerization on a
half-site might involve direct (DNA independent) interactions
between two Alx1 monomers. Previous studies on Cart1, a
vertebrate ortholog of Alx1, indicated that this protein can
dimerize in the absence of DNA (35). We therefore performed
glutathione-S-transferase (GST)-pulldown experiments using
Alx1-FL and four shortened forms of the protein: Alx1-Nterm
(which consisted of the 116 amino acids N-terminal to the
HD), Alx1-HD-D2 (which consisted of only the HD, D1, and
D2 domains), Alx1-Cterm (which consisted of the 183 amino
acids C-terminal to the D2 domain), and Alx1ΔD2. A pulldown using GST alone was used as a negative control.
GST-tagged proteins (or GST) were ﬁrst immobilized on
glutathione beads and then incubated with puriﬁed, Histagged, Alx1-FL (His-Alx1). We found that all GST-tagged
Alx1 protein fragments were subject to varying degrees of
degradation (Fig. 6A). These experiments showed that the
N- and C-terminal regions of Alx1 did not bind at detectable
levels to full-length, His-tagged Alx1, but the full-length protein bound (Fig. 6B, lanes 2, 4, and 5, respectively). The central
region consisting of only the HD, D1, and D2 domains was also
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capable of binding (Fig. 6B, lane 3). Deletion of the D2 domain
alone did not prevent binding to the full-length protein
(Fig. 6B, compare lanes 5 and 6), and binding was also detected
between Alx1-ΔD2 and Alx1-ΔD2 (Fig. S2), demonstrating
that the D2 domain of Alx1 was not required for DNAindependent interactions.
Alx1 and Alx4 have similar but distinct DNA-binding
properties and can form heterodimers
Given that Alx1 and Alx4 have distinct developmental
functions, we compared the DNA-binding properties of the
two proteins by EMSA. We found that Alx4 bound to the SpEMI/TM palindromic site as a dimer (Fig. 4A, lane 7), as did
Alx1-FL and Alx1-ΔD2 (Fig. 4A lanes 1 and 4, respectively). In
the case of Alx4, a slightly faster migrating complex was
detected because of the lower molecular weight of this protein.
Moreover, Alx4 was able to bind a DNA probe that contained
half sites A and B (Fig. 4B, lane 7), as did Alx1-FL and Alx1ΔD2 (Fig. 4B, lanes 1 and 4). Although the binding behaviors
of Alx1-FL and Alx4-FL appeared qualitatively similar, quantitative analysis of the binding of the two proteins to a Cy5-

DNA-binding properties of Alx1

Figure 3. Quantitative EMSA analysis of the binding of puriﬁed Alx1-FL and Alx1-ΔD2 proteins to the Sp-EMI/TM palindromic site. A, protein titration
of Alx1-FL with a constant amount of Cy5-labeled probe containing the Sp-EMI/TM palindromic site. B, protein titration of Alx1-ΔD2 with a constant amount
of Cy5-labeled probe containing the Sp-EMI/TM palindromic site. C, quantiﬁcation of representative gels as shown in panels A and B. Plot of the fraction of
probe bound as a function of protein concentration. Data are based on two independent replicates of the binding assay and are represented as the mean ±
1 SD. The ﬁlled circles denote Alx1-FL, and the ﬁlled squares denote Alx1-ΔD2. D, dimer to monomer ratios based on quantiﬁcation of the same two independent replicates shown in panel C with data represented as the mean ± 1 SD. Alx1-FL, full-length Alx1; Alx1-HD, Alx1 HD alone; Alx1ΔD2, a mutant form
of Alx1 that lacks the D2 domain; D, dimer; F, free probe; M, monomer.

labeled palindromic probe showed that Alx4-FL exhibited a
markedly lower dimer-to-monomer ratio across a wide range
of protein concentrations (Fig. 4, C–E).
GST-pulldown experiments showed that Alx1 and Alx4
were capable of interacting directly in the absence of DNA
(Fig. S3). We next tested whether these two proteins could
form heterodimers on DNA, using the Sp-EMI/TM palindromic Alx1 site as a target. When mixed, Alx1 and Alx4
formed heterodimers that migrated in gels at a position between Alx1:Alx1 and Alx4:Alx4 homodimers (Fig. S4A). The
presence of Alx1:Alx4 heterodimers was conﬁrmed by antibody super-shift experiments (Fig. S4C). These studies showed
that, at least in vitro, Alx1 and Alx4 are capable of forming
heterodimers on DNA. As discussed below, however, the
normal developmental expression patterns of alx1 and alx4
strongly suggest that, in vivo, the homodimeric form of Alx1
predominates over the heterodimeric form during PMC
speciﬁcation (see Discussion).
Binding of Alx1 to closely spaced half sites is noncooperative
As noted above, studies on paired-class HD proteins have
demonstrated that binding to palindromic sites occurs in a
cooperative fashion. We noted that half sites A and B were
separated by only 24 bp (~80 Å) in genomic DNA, raising the
possibility that two Alx1 molecules could interact directly with
one another across this distance (36) and bind cooperatively.
Using EMSA, we explored the possibility that Alx1 bound
cooperatively to a probe containing site A and site B by

examining the effect of increasing the spacing between these
two sites. An additional 15 bp were introduced between the
two half sites by inserting a direct repeat of part of the
endogenous sequence that separates these sites. This insertion
not only increased the distance separating the two half sites by
>60% but altered the relative position of the sites on the DNA
molecule by half of a helical turn. As a positive control, we
used a DNA probe of equal length that contained the Sp-EMI/
TM palindromic Alx1-binding site, ﬂanked by endogenous
genomic sequence. We observed the formation of dimeric
protein–DNA complexes with all three DNA probes tested
(Fig. 5A, lanes 1, 4, and 7). Quantitative EMSA analysis
conﬁrmed that altering the spacing and relative orientation of
sites A and B had very little or no effect on Alx1 binding
(Fig. 5, B and C).
We interpreted the pattern of complex formation on the
combined A and B sites as the binding of one Alx1 molecule
to each half site, which would be expected to create a
protein–DNA complex with the same electrophoretic
mobility as a complex containing two Alx1 molecules bound
to a single palindromic site. Because substantial dimer formation was observed on site B alone (Fig. 2A, lane 16),
however, we also predicted that higher order complexes
might form on a probe containing site A and site B. To
visualize such complexes, we lowered the overall mass by
using shorter probes (55 bp instead of the 70 bp used in
Fig. 5). Under these conditions, we detected complexes that
migrated more slowly than Alx1 dimers bound to a palindromic site (Fig. S5, lanes 1 and 4).
J. Biol. Chem. (2021) 297(1) 100901
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Figure 4. EMSA analysis comparing the binding of puriﬁed Alx1-FL and Alx4-FL proteins to DNA. Probes used in this analysis were all 70 bp in length
and included the Sp-EMI/TM palindromic site or two half sites (site A and site B) from the Sp-mtmmpb CRM. A and B, the binding capacities of Alx1, Alx1ΔD2,
and Alx4 were analyzed for each biotin-labeled DNA probe. Binding speciﬁcity was conﬁrmed by adding WT or mutant competitor. C, protein titration of
Alx4-FL with a constant amount of the Cy5-labeled probe containing the Sp-EMI/TM palindromic site. D, plot of the fraction bound as a function of protein
concentration, based on quantiﬁcation of representative gels as shown in panel C. Data are based on two independent replicates of the binding assay and
are represented as the mean ± 1 SD. The ﬁlled circles denote Alx1-FL, and empty circles denote Alx4-FL. Data for Alx1-FL are also based on two independent
replicates, distinct from those shown in Figure 3. E, dimer-to-monomer ratios based on quantiﬁcation of the same binding assays shown in panel C with
data represented as the mean ± 1 SD. For the complete sequences of all probes used in this study, see Table S1. Alx1-FL, full-length Alx1; CRM, cis-regulatory
module; D, dimer; F, free probe; M, monomer.

Transgenic reporter assays reveal a function for Alx1 half sites
in vivo
We examined the in vivo functions of the various Alx1binding sites in the Sp-mtmmpb CRM using transgenic reporter assays (Fig. 7). We injected fertilized Sp eggs with
linearized EpGFPII plasmids that contained the endogenous
210 bp CRM (or mutant forms of the CRM) cloned upstream
of a basal promoter and the coding sequence of GFP. Embryos
were collected 48 h after fertilization (prism stage) and
examined by ﬂuorescence microscopy. Foreign DNA is
incorporated and expressed in a highly mosaic fashion in sea
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urchin embryos; this requires the analysis of populations of
embryos to reconstruct the expression patterns of transgenes
(37). As reported previously, the endogenous Sp-mtmmpb
CRM drove robust expression of GFP, which was almost
entirely restricted to PMCs (~75% of GFP-expressing embryos;
see Fig. 7A). In contrast, a form of the CRM that had all four
Alx1-binding sites mutated failed to support appreciable GFP
expression. Notably, injection of a form of the CRM that
contained mutated A and B sites (but with intact C and D
sites) also resulted in dramatically reduced numbers of GFPexpressing embryos, and reporter expression was no longer

DNA-binding properties of Alx1

Figure 5. EMSA analysis demonstrating that binding of Alx1 to closely spaced half sites is noncooperative. A, all probes used were 70 bp in length
and included the Sp-EMI/TM palindromic site or two half sites (site A and site B) from the Sp-mtmmpb CRM. Additional nucleotides underlined were inserted
between site A and site B to increase the distance between the two sites and alter their relative orientation on the DNA helix. The added sequence was
designed by repeating the sequence underlined in the probe containing the two half sites to synthesize site A +++ site B probe. Binding speciﬁcity was
conﬁrmed by adding WT or mutant competitor. B, protein titration of Alx1-FL with constant amounts of two different Cy5-labeled probes containing sites A
and B. C, quantiﬁcation of the representative gel in panel B. Plot of the fraction bound as a function of protein concentration of two independent replicates
with the data represented as the mean ± SD. The ﬁlled squares denote the probe site A + site B, and the empty squares denote the probe site A +++ site B.
For the complete sequence of all probes used in this study, see Table S1. Alx1-FL, full-length Alx1; CRM, cis-regulatory module; F, free probe.

restricted to PMCs. Mutation of the A and B half sites individually resulted in reduced numbers of GFP-expressing
embryos and a reduced fraction of these embryos exhibited
PMC-restricted expression, but both constructs drove PMCspeciﬁc expression in a substantial fraction of embryos
(~60–70% of GFP-expressing embryos). These ﬁndings show
that Alx1 half sites play an important role in vivo in controlling
the lineage-restricted activity of the Sp-mtmmpb CRM and
that sites A and B have partially redundant functions in driving
the activity of this module in PMCs.

Discussion
Paired-class HD TF usage of palindromic and half sites
The cooperative binding of paired-class HD proteins to
palindromic DNA sites with the consensus sequence
TAATNNNATTA (also known as a P3 site) has been well
described (28, 29, 34). In vitro studies using puriﬁed Cart1 and
Alx4, members of the Alx1 gene family, demonstrate a
preferred interaction with this palindromic sequence (30, 31).
Our ChIP-seq studies, however, indicate that the majority of
Alx1-binding sites in vivo do not match this consensus
sequence and instead contain putative half sites with the
consensus core sequence TAAT (7). Indeed, despite much

evidence pointing to the importance of palindromic sites, other
in vitro binding studies have indicated that paired-class HD
proteins, including members of the Alx1 family, are capable of
interacting with half sites (28, 32). Notably, Perez-Villamil et al.
(38) showed that Alx3 binds to half sites associated with the
somatostatin promoter and that these sites can modulate the
transcriptional activity of reporter constructs in cell lines. More
recently, high-throughput reporter studies of Crx-binding sites
demonstrated binding to both half sites and palindromic sites,
although palindromic sites were associated with stronger
enhancer activity (33). The factors that operate in vivo to
regulate the binding of paired-class HD TFs to palindromic and
half sites, and the relative contributions of these two types of
binding sites to CRM activity, remain open questions.
In the present study, we analyzed a CRM associated with
Sp-mtmmpb, a gene expressed speciﬁcally in PMCs that receives essential, positive inputs from Alx1 (6). ChIP-seq
analysis shows that Alx1 binds directly to the 210 bp CRM
in vivo, and this DNA fragment is sufﬁcient to drive robust
expression of GFP selectively in PMCs in transgenic embryos
(7). We found that the Sp-mtmmpb CRM contains a single,
perfectly palindromic site which, although it diverges from
the canonical TAATNNNATTA sequence, supports HD
dimerization in vitro and therefore presumably functions as a
J. Biol. Chem. (2021) 297(1) 100901
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Figure 6. Alx1–Alx1 interactions in the absence of DNA. A, GST-tagged
Alx1 protein and various deletions mutants were expressed in Escherichia
coli and immobilized on glutathione beads. The protein samples were
separated on SDS-PAGE gels and visualized by Coomassie staining. B, GSTtagged, immobilized proteins shown in panel A were incubated with puriﬁed full-length, His-tagged Alx1. The beads were washed, separated on an
SDS-PAGE gel, and analyzed by Western blotting using an anti-His antibody.

typical P3 site. Surprisingly, we found that this site was not
required for robust, PMC-speciﬁc expression in transgenic
embryos. In contrast, deletion of both Alx1 half sites (sites A
and B) in the same construct dramatically reduced reporter
expression. Our studies demonstrate the functional signiﬁcance of Alx1 half sites in vivo and show that, at least in the
context of the 210 bp Sp-mtmmpb CRM, such sites make a
greater overall contribution to regulatory control than a bona
ﬁde palindromic site. Thus, although half sites represent
relatively low-afﬁnity binding sites in vitro compared to P3
sequences (30), they can play a major role in deﬁning target
speciﬁcity in vivo (39, 40).

How do half sites function? Although sites A and B are
located close to one another, several ﬁndings argue against the
hypothesis that these sites function in concert to support
cooperative dimerization of Alx1 molecules by the mechanism
that has been widely accepted for palindromic sites. Quantitative analysis of gel shifts showed no detectable effect of
inserting additional sequence that both increased the spacing
between the two sites and altered their orientation relative to
one another on the DNA duplex. It is difﬁcult to envision a
mechanism by which binding of the ﬁrst Alx1 molecule might
induce a change in complex conformation that would bring
the second site into close proximity regardless of the intervening sequence and the orientation of the two half sites on
the double-helical DNA. Indeed, studies with other pairedfamily HD proteins have shown that the addition of even
two additional base pairs between two half sites (i.e., converting a P3 site into a P5 site) reduces cooperative binding
(28). Moreover, we ﬁnd that the pattern of complex formation
on a DNA molecule with two half sites is very different from
that seen on a palindromic site (Fig. S5). Additional highmobility complexes are visible in the former case that likely
represent a mixture of independent, monomeric, and dimeric
binding events at each half site. This difference in complex
formation also argues against the view that the two half sites
are functioning like a single, palindromic site. Finally, our
in vivo assays showed that deletion of either half-site individually had little effect on reporter gene expression, a result that
would not be expected if activity were dependent upon a
cooperative interaction between the two half sites. Based on all
these considerations, we conclude that sites A and B function
independently and redundantly.

Figure 7. Analysis of the functional role of half sites in vivo using transgenic reporter assays. A, GFP expression in embryos injected with WT Spmtmmpb CRM and different Alx1-binding site mutants assayed by ﬂuorescence microscopy. B, representative embryos showing GFP expression. The scale
bar represents 50 μm. CRM, cis-regulatory module; PMC, primary mesenchyme cell.
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Our EMSA analysis provides the ﬁrst reported evidence of
HD protein dimerization on half sites and shows that the degree of dimerization in vitro varies among such sites. These
ﬁndings therefore blur the distinction between half sites
(which are often referred to as “monomeric” sites) and palindromic (“dimeric”) sites and suggest a continuum of binding
activities associated with a TAAT core sequence which can
promote varying degrees of protein dimerization. Our ﬁndings
indicate that this dimerization involves domains of the Alx1
protein outside the HD, as the isolated HD failed to dimerize
on the same half sites. We therefore propose that direct
protein–protein interactions drive dimerization on half sites,
consistent with our GST-pulldown data and with other evidence that Alx1 family proteins can dimerize in a DNAindependent fashion (35). A variety of factors might inﬂuence the extent of dimer formation on half sites in vivo,
including the local concentration of HD-containing TFs, the
speciﬁc DNA sequences that ﬂank the TAAT core, and the
presence of accessory proteins. There is abundant evidence
that dimerization is important for the robust, cooperative
activation of palindromic, P3 sites by paired-class HD proteins,
including Cart1 and Alx3 (28, 35, 38), and the formation of
dimers on half sites may have a similar impact on promoter
activation, although this has not been tested directly. Our
analysis of the Sp-mtmmpb CRM did not reveal a clear correlation between the ability of Alx1-binding sites (whether
palindromic or half sites) to mediate protein dimerization
in vitro and the regulatory contributions of these sites in
transgenic embryos, but the extent of dimer formation on
these sites in vivo may be quite different because of the presence of accessory proteins.
Evolution of Alx1 and the role of the D2 domain
Alx1 and Alx4 are paralogs that arose early in echinoderm
evolution through gene duplication (11, 24, 25). The two
proteins have almost identical HDs (97% amino acid identity)
and share a highly conserved otp/aristaless/rax domain but are
otherwise dissimilar in sequence. The alx1 and alx4 genes are
coexpressed selectively by PMCs early in embryogenesis, but
the onset of alx1 expression precedes that of alx4 by several
hours, and at the time of PMC differentiation, the level of alx1
mRNA in PMCs is >20-fold higher than that of alx4 mRNA
(5, 6). Thus, no Alx1:Alx4 heterodimers could exist early in
development (i.e., before the onset of alx4 expression) and
even at later stages; when our ﬁndings suggest that heterodimers could form, it seems very likely that the homodimeric
form of Alx1 is more abundant.
Experimental manipulations show that even when Alx1 and
Alx4 proteins are expressed at similar levels, only Alx1 has the
ability to activate downstream circuitry of the skeletogenic
network (25). This capacity is attributable to the D2 domain,
which is ordinarily absent from the paralogous Alx4 protein
but is sufﬁcient to confer skeletogenic function on a chimeric
form of Alx4 that contains the domain. The relatively recent
evolutionary acquisition of D2 and the importance of this
domain in endowing Alx1 with functional properties distinct

from those of Alx4 originally suggested a simple hypothesis
that Alx1 acquired new gene targets through D2-mediated
changes in direct DNA-binding speciﬁcity. In support of this
hypothesis, our studies reveal a role for the D2 domain in
regulating the DNA-binding properties of Alx1, as assessed by
quantitative gel-shift assays using a palindromic site shown
previously to be functional in vivo. Signiﬁcantly, we detected a
decrease in the dimer-to-monomer ratio when the D2 domain
was deleted from Alx1. Furthermore, full-length Alx4, which
lacks a D2 domain, also exhibited a reduced ability to form
dimers when compared with Alx1-FL. These ﬁndings suggest
that one effect of the D2 domain is to facilitate the cooperative
binding of an Alx1 molecule to an Alx1–DNA complex. Our
ﬁndings do not exclude the possibility, however, that the D2
domain also has an effect on the ability of Alx1 molecules to
form monomeric complexes on DNA. Although binding
curves for Alx1 and Alx4 were very similar, suggesting that
there was little difference in the Kd of monomer formation
between these two proteins, they were somewhat different
between Alx1-FL and Alx1ΔD2. Regardless of whether one or
both mechanisms are at work, our ﬁndings clearly show that
the in vitro DNA binding properties of Alx1 are affected by the
D2 domain.
Like other members of the protein family, Alx1 can engage
in DNA-independent dimerization. We did not detect a role
for the D2 domain in mediating such dimerization, although
GST-pulldown assays may not have detected subtle effects. In
addition, our in vitro studies involving puriﬁed Alx-family
proteins do not address the possibility that the D2 domain
inﬂuences heterodimer formation with other, as-yet unidentiﬁed, protein partners. There are several examples of the
regulation of HD protein target speciﬁcity through interactions
with protein partners (41, 42). To date, there has been no
systematic search for Alx1-interacting proteins, but vertebrate
members of the Alx family can interact directly with P300/CBP
(43) and a basic helix-loop-helix protein, E47 (44). Further
studies will be required to determine whether Alx1 interacts
with other proteins and, if so, whether the D2 domain inﬂuences such interactions. Although the ﬁndings reported
here do not exclude the possibility that the D2 domain plays
diverse roles in vivo, they provide the ﬁrst evidence that this
critically important, newly evolved domain has a direct role in
regulating the DNA-binding behavior of Alx1. We hypothesize
that the evolutionary recruitment of the D2 domain facilitated
the acquisition of new transcriptional targets at least in part by
modulating the DNA-binding properties of Alx1, thereby
allowing the protein to adopt a novel developmental function.

Experimental procedures
Animals
Adult S. purpuratus were acquired from Patrick Leahy
(California Institute of Technology). Release of gametes and
culture of embryos was performed as previously described (7).
Animal studies were carried out in accordance with the Carnegie Mellon University Institutional Animal Care and Use
Committee.
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Plasmids
A cDNA for Lytechinus variegatus Alx1 was used for PCRbased ampliﬁcation of segments that encoded Alx1-FL, the Nterminal region, HD, HD-D1-D2, and the C-terminal region.
L. variegatus Alx4 and Alx1ΔD2 cDNAs were ampliﬁed by
PCR from plasmids previously characterized (25). PCR also
introduced restriction sites for cloning into appropriate vectors and N-terminal tags (His and Flag) for bacterial expression and puriﬁcation: pTXB1 vector (Cat. No. N6707S; New
England Biolabs), pET-Duet-1 (Cat. No. 71146; Novagen), and
pGEX4T-1 (Cat. No. 28-9545-49; GE).
Protein expression and puriﬁcation
Plasmids were used to transform Rosetta 2 cells (Cat. No.
71400; Novagen). Bacterial cells were cultured at 37  C and
induced at an absorbance of 595 nm of 0.600 with 0.5 mM
IPTG. The temperature was lowered to 16  C, and cells were
allowed to grow for an additional 3 h and then collected and
centrifuged. All bacterial pellets were dissolved and sonicated
in a buffer containing 300 mM NaCl, 50 mM Tris, pH 6.8, 0.5%
Triton X-100, 20 mM sarcosine, 2 mM 2-mercaptoethanol,
and protease inhibitor cocktail. The mixture was sonicated and
then cleared through centrifugation. The lysate was diluted to
lower the concentration of detergents to a ﬁnal concentration
of 3.3 mM sarcosine and 0.16% Triton X-100.
For the puriﬁcation of Flag-Alx1-intein and Flag-Alx4intein, the bacterial lysate was loaded into a prepacked column of pre-equilibrated Flag-M2 agarose beads (Cat. No.
H0537; Sigma). Protein-bound Flag-M2 agarose beads were
then washed with a buffer containing 300 mM NaCl, 50 mM
Tris, pH 6.8, 0.1% Triton X-100, 2 mM 2-mercaptoethanol,
and protease inhibitor cocktail. The protein was eluted with
the same buffer containing Flag peptide (100 μg/ml). The
eluted protein was then incubated for 2 h with pre-equilibrated
chitin beads (Cat. No. S6651S; New England Biolabs) on a
rocker at 4  C. The mixture was loaded onto a column, and the
beads were washed with the buffer containing 300 mM NaCl,
50 mM Tris, pH 6.8, 0.1% Tris, pH 6.8, 0.1% Triton X-100,
2 mM 2-mercaptoethanol, and protease inhibitor cocktail. To
elute the protein, the column was sealed and incubated in the
wash buffer with 100 mM 2-mercaptoethanol for 40 h at 4  C.
The single tagged Flag-Alx1 and Flag-Alx4 protein were then
eluted, concentrated, and desalted.
Puriﬁcation of His-Alx1ΔD2-intein was performed as
described previously for His-Alx1-intein (7). Single-tagged
His-Alx1-HD was puriﬁed in the same way, except that after
the elution of the protein from the nickel beads, the sample
was desalted.
Lysates of GST-tagged proteins were incubated with
glutathione-agarose beads (Cat. No. 16100; Pierce) at room
temperature (RT) for 1 h on a rocker. The beads were then
washed several times, and the protein was left immobilized on
the beads.
The concentration of each protein was determined by
running the protein samples in parallel with BSA protein
standards on a TGX Stain-Free gel (Bio-Rad) and using
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Bio-Rad Image Lab software to image the gel and quantify the
bands.
Protein–protein interactions
Immobilized GST-tagged protein were incubated overnight with His-Alx1 in a buffer containing 200 mM NaCl,
50 mM Tris, pH 6.8, 0.1% Triton X-100, 2 mM 2mercaptoethanol, and protease inhibitor cocktail and
placed on a rotating rocker at 4  C. The beads were washed
several times and resuspended in the loading buffer, and
samples were separated on 10% polyacrylamide gels. Western blot procedures and visualization were carried out using
standard procedures. The anti-His monoclonal antibody
(Thermo Fisher Scientiﬁc, Cat. No. MA1-135) and
secondary-HRP antibody (Cat. No. 115-035-146; Jackson
ImmunoResearch) were diluted in 5% nonfat dried milk in
TBS containing 0.1% Tween-20.
EMSAs
EMSAs were performed as described previously (7), with the
modiﬁcation that 40 fmol of probe and 8 pmol of nonbiotinylated probe competitor were used per reaction. The
sequences of all probes used in this study are shown in
Table S1. The binding conditions were 75 mM NaCl, 15 mM
Tris, pH 7.6, 7.5% glycerol, 2 mM MgCl2, 1.5 mM EDTA, 0.1%
NP-40, 40 mM DTT, 50 μg BSA, and 1 μg poly(dI-dC) per
20 μl reaction. For most studies, DNA probes were synthesized, biotinylated (when applicable), and puriﬁed (either
through gel or HPLC) by Thermo Fisher Scientiﬁc. Reactions
were incubated with the binding buffer and protein on ice for
15 min. Competitor nonbiotinylated probes were then added
and the reactions incubated for an additional 20 min at RT.
Biotinylated probes were then added, and the reactions incubated for an additional 25 min at RT. The free probes and
protein–DNA complexes were separated on 8% polyacrylamide gels and visualized using the LightShift Chemiluminescent EMSA kit (Cat. No. 20148, Thermo Fisher
Scientiﬁc). Images were collected using Bio-Rad Image Lab
software.
For quantitative EMSA studies (i.e., titrations of Alx1-FL,
Alx4-FL, and Alx1ΔD2), probes labeled with Cy5 were obtained from Integrated DNA Technologies. The binding conditions were as above, but the amount of Cy5 probe used was
1 nM per reaction. The nanomolar range of protein titration
for Alx1-FL and Alx1- ΔD2 was 0, 12, 24, 36, 48, 72, 97, 194,
291, and 388 nM. The nanomolar range for the Alx4-FL was 0,
9, 18, 27, 37, 55, 74, 148, 222, and 296 nM. Gels were scanned
using a Typhoon FLA 9000 (GE Healthcare), and bands were
quantiﬁed using ImageQuant TL from the same company.
Background subtractions and band area selections were done
according to Altschuler et al. (45). The fraction of the probe
bound at each protein concentration was calculated as follows:
(monomer + dimer)/(monomer + dimer + free probe). The
fraction bound as a function of protein concentration was
graphed using GraphPad Prism (version 9 for Mac; GraphPad
Software; https://graphpad.com). The parameters selected to
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create the curves were “nonlinear regression” and “two-site–
speciﬁc binding”.
The active fraction of each protein preparation was determined in a set of binding reactions using a constant concentration of protein (5 nM, as determined above) and increasing
concentrations of Cy5-labeled, palindromic oligo, without
nonspeciﬁc competitor DNA. Bound complexes and free oligo
were quantiﬁed for each concentration of oligo, and the active
concentration of protein was estimated from each pair of data
points using the formula shown in Fig. S6. The average of these
estimates divided by the initial determination of protein concentration was taken as the active fraction of protein.
For super-shift experiments, we used custom-made, afﬁnitypuriﬁed rabbit polyclonal antibodies monospeciﬁc for Alx1
and Alx4 (Biomatik). The Alx1 antibody was described previously (7). The Alx4 antibody was raised against the synthetic
peptide sequence Cys-TGGVEPIETDRRSHS, and the speciﬁcity of the antibody was conﬁrmed by immunoblotting
(Fig. S4B).
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